Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Other

3

US Previously Marketed

3

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Phase III

3

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

2010

3

Unknown

3

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Anal high-grade squamous intraepithelial lesions

3

Melasma

3

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Palliative

3

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Dumas, J.-B.

3

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

6

All Match

Any Match

Exclude Selected

Exclude Selected

INN Stem

Chemical substance(-ine)

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

CAS

6

ECHA (EC/EINECS)

6

EPA CompTox

6

FDA UNII

6

PUBCHEM

6

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

4

Salts, Hydrates, Esters, etc.

2

All Match

Any Match

Exclude Selected

Exclude Selected

Showing 1 - 6 of 6 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

METHYL 3-AMINO-4-METHYLTHIOPHENE-2-CARBOXYLATE

3LA24473AS

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

2-ETHYLPYRIDINE

06X1W46PYX

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

2-AMINO-3-HYDROXYPYRIDINE

P8740PEW4B

Export Data
Search for Structure

Status:

Other

Class (Stereo):

CHEMICAL (ACHIRAL)

Trichloroacetic acid

5V2JDO056X

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 2010

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Anal high-grade squamous intraepithelial lesions

Trichloroacetic acid (TCA; TCAA) is a chemical used in skin peel formulations. It is more frequently used for lighter skin and is less used on darker skin because of the higher risks of scarring, as well as post-peel dyschromias. Low concentrations, ...

10-35% is preferred for skin peel formulations so that it only reaches the upper papillary dermis. Topical TCA is an efficacious treatment of internal anal high-grade squamous intraepithelial lesions (HSIL). Advantages of TCA for this recurrent disease process include low cost, no requirement for special equipment beyond that for high-resolution anoscopy, and painless application procedure.

SODIUM TRICHLOROACETATE

2N76A3BRJ0

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 2010

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Anal high-grade squamous intraepithelial lesions

Trichloroacetic acid (TCA; TCAA) is a chemical used in skin peel formulations. It is more frequently used for lighter skin and is less used on darker skin because of the higher risks of scarring, as well as post-peel dyschromias. Low concentrations, ...

10-35% is preferred for skin peel formulations so that it only reaches the upper papillary dermis. Topical TCA is an efficacious treatment of internal anal high-grade squamous intraepithelial lesions (HSIL). Advantages of TCA for this recurrent disease process include low cost, no requirement for special equipment beyond that for high-resolution anoscopy, and painless application procedure.

AMMONIUM TRICHLOROACETATE

7PL9R555XT

Export Data
Search for Structure

Status:

US Previously Marketed

First approved in 2010

Class (Stereo):

CHEMICAL (ACHIRAL)

Conditions:

Anal high-grade squamous intraepithelial lesions

Trichloroacetic acid (TCA; TCAA) is a chemical used in skin peel formulations. It is more frequently used for lighter skin and is less used on darker skin because of the higher risks of scarring, as well as post-peel dyschromias. Low concentrations, ...

10-35% is preferred for skin peel formulations so that it only reaches the upper papillary dermis. Topical TCA is an efficacious treatment of internal anal high-grade squamous intraepithelial lesions (HSIL). Advantages of TCA for this recurrent disease process include low cost, no requirement for special equipment beyond that for high-resolution anoscopy, and painless application procedure.

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1